1. Summary Information

 

 

Country

India

Company Name

THEON PHARMACEUTICALS LIMITED

Principal Name 1

Mr. Bal Krishan Bansal

Status

Satisfactory

Principal Name 2

Mr. Mukesh Bansal

 

 

Registration #

53-028465

Street Address

# 50, Sector - 28 A, Chandigarh – 160026

Established Date

26.05.2005

SIC Code

--

Telephone#

91-172-5210200

Business Style 1

Manufacturer 

Fax #

91-172-5033851

Business Style 2

--

Homepage

http://www.theonpharma.com 

Product Name 1

Pharmaceutical Formulation

# of employees

Not Available

Product Name 2

--

Paid up capital

Rs.26,250,000/-

Product Name 3

--

Shareholders

Directors or relatives of directors – 100%

Banking

HDFC Bank Limited

Public Limited Corp.

NO

Business Period

8 Years

IPO

NO

International Ins.

-

Public Enterprise

NO

Rating

Ba (46)

Related Company

Relation

Country

Company Name

CEO

--

--

--

--

Note

-

 

2. Summary Financial Statement

Balance Sheet as of

31.03.2012

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

589,162,000

Current Liabilities

466,470,000

Inventories

180,938,000

Long-term Liabilities

198,785,000

Fixed Assets

295,284,000

Other Liabilities

25,776,000

Deferred Assets

0,000

Total Liabilities

691,031,000

Invest& other Assets

50,000

Retained Earnings

348,153,000

 

 

Net Worth

374,403,000

Total Assets

1,065,434,000

Total Liab. & Equity

1,065,434,000

 Total Assets

(Previous Year)

628,379,000

 

 

P/L Statement as of

31.03.2012

(Unit: Indian Rs.)

Sales

1,521,094,000

Net Profit

195,380,000

Sales(Previous yr)

1,051,734,000

Net Profit(Prev.yr)

122,625,000

 

 

 

MIRA INFORM REPORT

 

 

Report Date :

08.01.2013

 

IDENTIFICATION DETAILS

 

Name :

THEON PHARMACEUTICALS LIMITED

 

 

Registered Office :

# 50, Sector - 28 A, Chandigarh – 160026

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

26.05.2005

 

 

Com. Reg. No.:

53-028465

 

 

Capital Investment / Paid-up Capital :

Rs.26.250 Millions

 

 

CIN No.:

[Company Identification No.]

U24231CH2005PLC028465

 

 

PAN No.:

[Permanent Account No.]

AACCT2692J

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Formulation. 

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1500000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

It has recorded better growth in its sales turnover and profits during 2012.

 

Trade relations are reported as decent. Business is active. Payment terms are usually correct and as per commitment.

 

The company can be considered normal for business dealings at usual trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

TERM LOAN AND CASH CREDIT : CRISIL BBB

Rating Explanation

Moderate degree of safety and moderate credit risk.

Date

24.11.2011

 

Rating Agency Name

CRISIL

Rating

LETTER OF CREDIT : A3+

Rating Explanation

Moderate degree of safety and higher credit risk

Date

24.11.2011

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office :

# 50, Sector - 28 A, Chandigarh – 160026, India

Tel. No.:

91-172-5210200

Fax No.:

91-172-5033851

E-Mail :

parularoracs@gmail.com

Website :

http://www.theonpharma.com 

 

 

Corporate Office :

Plot No-400, Industrial Area, Phase-1, Panchkula-134113, Haryana, India

Tel. No.:

91-172-5011077 / 5210200

Fax No.:

91-172-5033851

E-Mail :

contract@theonpharma.com

mohitsharma@theonpharma.com

admin@theonpharma.com

rashidshaikh@theonpharma.com

 

 

Factory :

Village Saini Majra, Tehsil Nalagarh District Solan, Himachal Pradesh, India

Tel. No.:

91-1795-309200 / 265303 / 265304 / 669200

Fax No.:

91-1795-309295 and 265302

E-Mail :

info@theonpharma.com

purchase@theonpharma.com 

 

 

DIRECTORS

 

As on 29.09.2012

 

Name :

Mr. Bal Krishan Bansal

Designation :

Director

Address :

H. No.222, Sector-7, Panchkula, Haryana, India 

Date of Birth/Age :

15.01.1953

Date of Appointment :

27.05.2005

PAN No.:

ADBPK3195Q

DIN No.:

00548350

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231CH2005PLC028465

THEON PHARMACEUTICALS LIMITED

Director

27/05/2005

27/05/2005

-

Active

NO

2

U70100CH2005PTC028911

DIPLOMAT HOTELS PRIVATE LIMITED

Director

05/09/2005

05/09/2005

-

Strike off

NO

3

U72900KA2009PTC050123

WS RETAIL SERVICES PRIVATE LIMITED

Director

28/02/2011

14/02/2011

06/09/2012

Active

NO

 

Name :

Mr. Mukesh Bansal

Designation :

Director

Address :

H. No.222, Sector-7, Panchkula, Haryana, India 

Date of Birth/Age :

18.06.1979

Date of Appointment :

27.05.2005

DIN No.:

00548369

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231CH2005PLC028465

THEON PHARMACEUTICALS LIMITED

Director

27/05/2005

27/05/2005

Active

NO

2

U21022CH2010PTC032393

ISIS PACKAGING PRIVATE LIMITED

Director

12/08/2010

12/08/2010

Active

NO

 

 

Name :

Mr. Lajpat Rai Bansal

Designation :

Whole-time director

Address :

H. No.222, Sector-7, Panchkula, Haryana, India 

Date of Birth/Age :

01.07.1960

Date of Appointment :

10.05.2006

PAN No.:

AAUPB5619G

DIN No.:

00548376

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U70100CH2005PTC028911

DIPLOMAT HOTELS PRIVATE LIMITED

Director

05/09/2005

05/09/2005

Strike off

NO

2

U24231CH2005PLC028465

THEON PHARMACEUTICALS LIMITED

Whole-time director

01/01/2012

10/05/2006

Active

NO

3

U21022CH2010PTC032393

ISIS PACKAGING PRIVATE LIMITED

Director

12/08/2010

12/08/2010

Active

NO

 

 

Name :

Mr. Anshul Bansal

Designation :

Whole-time director

Address :

H. No.203, Sector-7, Panchkula, Haryana, India 

Date of Birth/Age :

08.03.1985

Date of Appointment :

27.05.2005

PAN No.:

AIOPB3430B

DIN No.:

00548418

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231CH2005PLC028465

THEON PHARMACEUTICALS LIMITED

Whole-time director

01/04/2011

27/05/2005

Active

NO

2

U51397CH2009PTC031474

IVA HEALTHCARE PRIVATE LIMITED

Director

06/01/2009

06/01/2009

Active

NO

 

 

Name :

Mr. Punit Bansal

Designation :

Whole-time director

Address :

H No. 109, Sector-7, Panchkula, Haryana, India

Date of Birth/Age :

12.08.1984

Date of Appointment :

10.05.2006

DIN No.:

00548436

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231CH2005PLC028465

THEON PHARMACEUTICALS LIMITED

Whole-time director

01/04/2011

10/05/2006

Active

NO

2

U51397CH2009PTC031474

IVA HEALTHCARE PRIVATE LIMITED

Director

12/01/2009

12/01/2009

Active

NO

 

 

Name :

Mr. Manish Bansal

Designation :

Director

Address :

H No.64, Sector 28-A, Chandigarh, India

Date of Birth/Age :

13.11.1978

Date of Appointment :

08.07.2005

DIN No.:

00548494

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231CH2005PLC028465

THEON PHARMACEUTICALS LIMITED

Director

01/04/2009

08/07/2005

Active

NO

2

U51397CH2009PTC031474

IVA HEALTHCARE PRIVATE LIMITED

Director

06/01/2009

06/01/2009

Active

NO

3

U21022CH2010PTC032393

ISIS PACKAGING PRIVATE LIMITED

Director

15/10/2011

11/02/2011

Active

NO

 

 

Name :

Mr. Amit Kumar Bansal

Designation :

Managing director

Address :

H No.64, Sector 28-A, Chandigarh, India

Date of Birth/Age :

24.04.1976

Date of Appointment :

08.07.2005

PAN No.:

ABBPB9319H

DIN No.:

01183281

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231CH2005PLC028465

THEON PHARMACEUTICALS LIMITED

Managing director

01/04/2011

08/07/2005

Active

NO

2

U51410CH2006PLC029773

BANSI RAUNAQ ENERGY GROUP LIMITED

Director

23/02/2006

23/02/2006

Active

NO

3

U21022CH2010PTC032393

ISIS PACKAGING PRIVATE LIMITED

Director

12/08/2010

12/08/2010

Active

NO

 

 

Name :

Ms. Madhu Bansal

Designation :

Whole-time director

Address :

H No.64, Sector 28-A, Chandigarh, India

Date of Birth/Age :

17.06.1953

Date of Appointment :

08.07.2005

PAN No.:

APSPB7922D

DIN No.:

02428389

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231CH2005PLC028465

THEON PHARMACEUTICALS LIMITED

Whole-time director

01/04/2010

08/07/2005

Active

NO

2

U51397CH2009PTC031474

IVA HEALTHCARE PRIVATE LIMITED

Director

12/01/2009

12/01/2009

Active

NO

 

 

Name :

Ms. Shiana Bansal

Designation :

Whole-time director

Address :

H No.64, Sector 28-A, Chandigarh, India

Date of Birth/Age :

23.06.1982

Date of Appointment :

01.04.2010

DIN No.:

03062085

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231CH2005PLC028465

THEON PHARMACEUTICALS LIMITED

Whole-time director

01/04/2010

01/04/2010

Active

NO

2

U21022CH2010PTC032393

ISIS PACKAGING PRIVATE LIMITED

Director

12/08/2010

12/08/2010

Active

NO

 

 

Name :

Ms. Monika Bansal

Designation :

Whole-time director

Address :

H No.64, Sector 28-A, Chandigarh, India

Date of Birth/Age :

23.09.1980

Date of Appointment :

08.07.2005

DIN No.:

00633294

 

 

Name :

Mr. Puran Chand Joshi

Designation :

Whole-time director

Address :

H No.117/B1, Ward No 2, Model Town, Pinjore, Haryana, India

Date of Birth/Age :

30.10.1966

Date of Appointment :

05.10.2011

DIN No.:

05216099

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 29.09.2012

 

Names of Shareholders

 

No. of Shares

 

 

 

Amit Kumar Bansal

 

402000

Monika Bansal

 

105000

Manish Bansal

 

399000

Madhu Bansal

 

406500

. Bal Krishan Bansal

 

302250

Mukesh Bansal

 

285000

Punit Bansal

 

130500

Lajpat Rai Bansal

 

174750

Anshul Bansal

 

157500

Brij Bala

 

262500

Total

 

2625000

 

Equity Share Break up (Percentage of Total Equity)

 

As on 29.09.2012

 

Category

 

Percentage

Directors or relatives of directors

 

100.00

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Formulation. 

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         HDFC Bank Limited, HDFC Bank House, Senapati Bapat Marg, Lower Parel (West), Mumbai – 400013, Maharashtra, India

 

·         Canara Bank, Sco 117-118-119, Sector 17C, Chandigarh – 160017, India  

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2012

As on

31.03.2011

 

 

 

Term Loan – From Banks

 

 

HDFC Bank Limited

16.352

0.000

HDFC Bank Limited

93.824

0.000

Canara Bank

0.000

24.179

 

 

 

From Banks

 

 

Buyer’s Credit

0.000

12.116

Cash Credit A/c

76.209

88.291

Total

186.385

124.586

 

Unsecured Loan

As on

31.03.2012

As on

31.03.2011

 

 

 

Loans and advances from related parties

12.400

12.400

Total

12.400

12.400

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S Kumar Gupta and Associates

Chartered Accountants

PAN No.:

AECPG2057F

 

 

CAPITAL STRUCTURE

 

As on 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4000000

Equity Shares

Rs.10/- each

Rs.40.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2625000

Equity Shares

Rs.10/- each

Rs.26.250 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

26.250

17.500

17.500

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

348.153

186.743

81.646

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

374.403

204.243

99.146

LOAN FUNDS

 

 

 

1] Secured Loans

186.385

124.586

89.355

2] Unsecured Loans

12.400

12.400

12.400

TOTAL BORROWING

198.785

136.986

101.755

DEFERRED TAX LIABILITIES

12.014

11.476

10.063

 

 

 

 

TOTAL

585.202

352.705

210.964

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

295.284

174.218

150.166

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.050

0.050

0.050

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

180.938

95.697

82.274

 

Sundry Debtors

439.691

306.008

176.043

 

Cash & Bank Balances

11.613

3.907

2.372

 

Other Current Assets

0.658

0.035

0.000

 

Loans & Advances

137.200

48.464

27.593

Total Current Assets

770.100

454.111

288.282

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

412.957

239.420

176.326

 

Other Current Liabilities

53.513

23.368

3.805

 

Provisions

13.762

12.886

47.436

Total Current Liabilities

480.232

275.674

227.567

Net Current Assets

289.868

178.437

60.715

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.033

 

 

 

 

TOTAL

585.202

352.705

210.964

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

1521.094

1051.734

616.791

 

 

Other Income

0.539

1.036

0.119

 

 

TOTAL                                     (A)

1521.633

1052.770

616.910

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

1121.948

798.743

548.489

 

 

Changes in inventories of finished goods and work-in-progress

(5.477)

(1.228)

 

 

 

Employee benefits expenses

49.305

25.629

 

 

 

Other manufacturing expenses

52.685

39.767

 

 

 

Administration Expenses

48.035

25.804

 

 

 

Selling and Distribution Expenses

25.796

13.859

 

 

 

TOTAL                                     (B)

1292.292

902.574

548.489

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

229.341

150.196

68.421

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

16.351

13.576

14.782

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

212.990

136.620

53.639

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

15.682

14.130

11.282

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

197.308

122.490

64.921

 

 

 

 

 

Less

TAX                                                                  (H)

1.928

0.135

5.445

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

195.380

122.625

59.476

 

 

 

 

 

 

Earnings Per Share (Rs.)

74.43

46.71

23.00

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

12.84

11.65

9.64

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

12.97

11.65

10.53

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

18.52

19.49

14.81

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.53

0.60

0.65

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.81

2.02

3.32

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.60

1.65

1.27

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

CONTINGENT LIABILITY:

(Rs. In Millions)

Particulars

31.03.2012

31.03.2011

Claims against the company not acknowledge as debt 

0.249

0.000

Inter Corporate Guarantees (for ISIS Packing Private Limited)  

24.000

0.000

Performance bank Guarantee

7.332

0.000

Letter of Credit on Capital Goods (LC opened but goods not received till 31.03.2012)

1.551

0.000

LC discounted (netted off from debtors)

1.374

0.950

 

 

FIXED ASSETS:

 

·         Land and Building

·         Vehicles (Commercial and Passenger)

·         Office and Plant Furniture

·         Computers

·         Lab Items

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.98

UK Pound

1

Rs.88.11

Euro

1

Rs.71.67

 

 

INFORMATION DETAILS

           

Report Prepared by :

BSN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.